News | Pediatric Cardiology | January 06, 2023

New Pediatric Investigation Article Reviews the Potential of Transcatheter Pulmonary Valve Replacement for Congenital Heart Disorders

Heart patients with a dysfunctional or leaky pulmonary valve can benefit from a non-surgical procedure called transcatheter pulmonary valve replacement

The ensemble delivery system of the Melody valve.

The ensemble delivery system of the Melody valve.

January 6, 2023 — Patients with congenital heart diseases often suffer from obstructions in the right ventricular outflow tract (RVOT), which carries blood from the heart to the lungs. These obstructions can be repaired with surgical procedures. However, these are temporary fixes that can still result in pulmonary stenosis and/or regurgitation, eventually leading to RVOT dysfunction and even fatal arrhythmias. Often, heart patients require pulmonary valve replacement (PVR) surgery; using bioprosthetic valves made from materials derived from cows or pigs, which deteriorate over time. This results in patients needing valve replacement surgeries throughout their lives, which increases the risk of surgical complications. To minimize the need for multiple surgeries and their resultant risks, medical researchers have been trying to find robust alternatives to surgical PVR. To this end, transcatheter PVR (TPVR) has emerged as a potential non-surgical option to restore RVOT and pulmonary valve functions without the concomitant surgical risks.

In this review article, Professor Adolphus Kai-Tung Chau from the Chinese University of Hong Kong Medical Centre discusses the benefits, challenges, clinical considerations, outcomes, and developments in the application of TPVR. The article was made available online on December 5, 2022, in an Early View version of Pediatric InvestigationDifferent cardiology societies may adopt slightly different criteria for TPVR for both symptomatic and asymptomatic patients. But given that this procedure is minimally invasive compared to surgical PVR, it is likely that more asymptomatic patients may benefit from it,” says Prof. Chau.

The TPVR procedure requires a thorough pre-procedural evaluation, including patient history, physical examination, chest radiographs, electro- and echo-cardiograms, and imaging tests to ascertain the morphology of the RVOT and the presence of existing pulmonary complications. The surgical plan for individual patients is ideally determined by a multidisciplinary team of specialists.

Before the procedure, anatomical and hemodynamic data are assessed along with the assessment of the coronary artery and aorta. Next, the RVOT conduit is prepared for the implantation with pre-stenting and serial balloon dilation to ensure adequate pressure in the right ventricle and avoid valve failure.

What makes the TPVR procedure minimally invasive? Unlike conventional open-heart surgery, TPVR is conducted by guiding a hollow transcatheter tube through the femoral or jugular vein into the heart. The valve is implanted and set in position via balloon dilation. Following the implant, post-procedure hemodynamic data and angiograms are obtained to assess valve competence and check for perivalvular leak.

An advantage of the TPVR is that it can also be safely used for valve-in-valve conditions, where a new transcatheter valve is placed inside the hole of the failed valve after minor alterations.

Lately, trials are being conducted to adapt the application of TPVR for valve implantation in native, large, or variably shaped RVOTs, through self-expanding, partially covered stents that can fit into a wide range of RVOT shapes and sizes.

As of now, the Harmony and Edward Sapien valves are the only TPVR-compatible valves approved by the United States Food and Drug Administration (FDA). However, newer valves are continuously being developed and tested with promising results.

Long-term results indicate that TPVR can effectively restore RVOT function, while improving survival rates and reducing the need for reintervention across age groups. Nevertheless, vigilant testing is recommended to avoid endocarditis and coronary artery compression, which are rare but serious complications of TPVR. Although TPVR and surgical PVR have similar outcomes in terms of mortality rates and cardiovascular readmissions, TPVR leads to shorter hospital stays that benefit both patients and their caregivers.

In conclusion, this less invasive procedure is capable of providing safe and durable long-term outcomes, which makes it an important and preferred option for patients with congenital heart diseases. “TPVR is constantly evolving and undergoing improvement in efficacy and safety. With more long-term results from trials and better delivery systems, TPVR might also be useful as an initial repair option for younger and growing children,” envisions Prof. Chau. 

For more information:

Recent Technology Advances in Congenital Heart:

FDA Clears First Device to Treat Right Ventricular Outflow Tract Congenital Heart Disease 

VIDEO: Harmony Transcatheter Pulmonary Valve Has Good Outcomes at 1 Year — Interview with Tom Jones, M.D.

Medtronic Harmony Transcatheter Pulmonary Valve Demonstrates Positive Early Clinical Outcomes at One Year

FDA Expands Indication for Melody Transcatheter Valve for Failed Surgical Valves

VIDEO: Use of Virtual Reality to Aid Congenital Heart Disease — Interview with David M. Axelrod, M.D.

Bioresorbable Pulmonary Valve Replacement May Enable Cardiovascular Regeneration

VIDEO: Transcatheter Closure of Holes in the Heart — Interview with Ziyad Hijazi, M.D.

Nemours Children's Health System Uses 3-D Printing to Deliver Personalized Care

Children's Hospital Los Angeles Cardiologist Creates Modified Stent for 18-month-old Using Printed 3-D Model

PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials

Bioresorbable ASD Occluder Prepares to Enter U.S. Clinical Trial

FDA Approves Abbott's Amplatzer Piccolo Occluder

Critical Need for Pediatric Electrophysiology Devices is Focus of Medical Device Competition 

Lab-created Heart Valves Can Grow With the Patient

SCAI Issues Position Statement on Adult Congenital Cardiac Interventional Training, Competencies and Organizational Recommendations

Abbott Receives European CE Mark for Two Pediatric Heart Devices

ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease

Find more congenital heart disease (CHD) content

Related Content

News | Pediatric Cardiology

March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder ...

Home March 29, 2024
News | Pediatric Cardiology

March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a ...

Home March 01, 2024
News | Pediatric Cardiology

February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center ...

Home February 28, 2024
News | Pediatric Cardiology

February 21, 2024 — Ochsner Children's Hospital, ranked among the top hospitals in the nation for pediatric cardiology ...

Home February 21, 2024
News | Pediatric Cardiology

February 13, 2024 — Pediatric heart transplantation has long been hailed as a life-saving intervention for children ...

Home February 13, 2024
News | Pediatric Cardiology

December 5, 2023 — David Epstein, MD, a pediatrician who has dedicated his career to caring for very ill children, has ...

Home December 05, 2023
News | Pediatric Cardiology

November 20, 2023 — In the U.S., nearly 10,000 children and adolescents have developed a condition called multisystem ...

Home November 20, 2023
News | Pediatric Cardiology

October 6, 2023 — Rady Children’s Hospital-San Diego, the largest children’s hospital on the West Coast and one of the ...

Home October 06, 2023
News | Pediatric Cardiology

October 3, 2023 — A discovery of a mutation in the gene ACTA2 has given researchers, led by Dianna Milewicz, MD, PhD ...

Home October 03, 2023
News | Pediatric Cardiology

August 23, 2023 — Researchers from Nemours Children’s Health will present a range of studies at the World Congress of ...

Home August 23, 2023
Subscribe Now